Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 1-palmitoyl-2-oleoylphosphatidylcholine

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 1-palmitoyl-2-oleoylphosphatidylcholine in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(1-palmitoyl-2-oleoylphosphatidylcholine)
Trials
(1-palmitoyl-2-oleoylphosphatidylcholine)
Recent Studies (post-2010) (1-palmitoyl-2-oleoylphosphatidylcholine)
9,1561875521,9783932

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Friedman, M; Kafoury, RM; Pryor, WA; Salgo, MG; Squadrito, GL; Zou, X1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 1-palmitoyl-2-oleoylphosphatidylcholine

ArticleYear
Induction of inflammatory mediators in human airway epithelial cells by lipid ozonation products.
    American journal of respiratory and critical care medicine, 1999, Volume: 160, Issue:6

    Topics: Alkanes; Bronchi; Cells, Cultured; Dinoprostone; Enzyme Activation; Epithelial Cells; Humans; Inflammation Mediators; Interleukin-6; Interleukin-8; Membrane Lipids; Oxidants, Photochemical; Ozone; Peroxides; Phosphatidylcholines; Phospholipases A; Platelet Activating Factor; Type C Phospholipases

1999